Results 21 to 30 of about 9,749 (194)

Study of noninduction immunosuppression in intermediate-risk living donor kidney transplantation in rural population of India - A retrospective observational study

Indian Journal of Transplantation, 2022
Introduction: Kidney transplant is a costly affair, especially in a developing country like India. The current study was carried out with the aim to analyze the clinical outcome retrospectively in terms of acute rejection (AR), graft survival, and ...
Ankit Data, Kshitija G Gadekar, Vajed R Mogal, Abhijeet S More, Sudhir Gajanan Kulkarni   +4 more
doaj   +1 more source

Outcomes in live renal allograft transplants with different modalities of induction: A hospital-based retrospective study in Odisha

Indian Journal of Transplantation, 2022
Introduction: The immunosuppressant regimen after kidney transplantation typically includes initial induction therapy followed by a maintenance regimen. The induction therapy was introduced with the aim of reducing acute rejections. A retrospective study
Datteswar Hota, Sucharita Chakraborty, Kumar Avijeet Dash, Chittaranjan Kar, Shashi Bhusan Rout, Aruna Acharya, Debasish Mahali   +6 more
doaj   +1 more source

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. [PDF]

PLoS ONE, 2013
Immunosuppression therapy following liver transplantation often includes steroids. However, extended corticosteroid therapy is associated with numerous complications.
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng   +5 more
doaj   +1 more source

A comparative study of recipients' outcomes receiving a kidney from the same deceased donor: An observational study

Indian Journal of Transplantation, 2022
Introduction: Kidney transplantation is the renal replacement therapy (RRT) of choice for patients with end-stage renal disease. Although outcomes of deceased-donor kidney transplantation are inferior when compared to live donor kidney transplantation ...
A Ayyappa, Manisha Sahay, Kiran Mai Ismal, P Sharmas Vali, Samuel Raju Palli, Swarnalata G   +5 more
doaj   +1 more source

Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report

Frontiers in Immunology, 2022
A 66-year-old Chinese man underwent a deceased donor kidney transplantation. Induction-immunosuppressive protocol consisted of basiliximab (BAS) and methyl prednisolone (MP), followed by maintenance immunosuppression with cyclosporin (CsA), mycophenolate
Tingting Chen, Xiaoyu Li, Jina Wang, Jina Wang, Xuanchuan Wang, Xuanchuan Wang, Tongyu Zhu, Tongyu Zhu, Ruiming Rong, Ruiming Rong, Ruiming Rong, Cheng Yang, Cheng Yang, Cheng Yang   +13 more
doaj   +1 more source

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundBasiliximab and anti‐thymocyte globulin are widely used drugs for induction therapy after pediatric heart transplantation. The aim of this study was to determine whether any differences could be observed between basiliximab and anti‐thymocyte ...
David Ansari, Peter Höglund, Bodil Andersson, Johan Nilsson   +3 more
doaj   +1 more source

Basiliximab vs. Antithymocyte Globulin as Initial Induction Therapy for Lung Transplantation: A National Two Years Review

Transplantology, 2022
Basiliximab (BAS) is an interleukin-2 monoclonal antibody initially used as induction therapy after liver and kidney transplantation. BAS use after lung transplantation (LTx) has supplanted antithymocyte globulin (ATG) as the main induction ...
Bruno Mendes, Carlos Figueiredo, Mariana Cabral, Alexandra Borba, Alexandra Mineiro, João Cardoso, Paulo Calvinho, Luísa Semedo, José Fragata   +8 more
doaj   +1 more source

Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression

Indian Journal of Transplantation, 2019
Introduction: Interleukin-2 receptor antagonists are recommended to reduce the risk of acute rejection (AR) in kidney transplant. This prospective study was undertaken to compare the incidence of AR with basiliximab induction as compared to no induction ...
Shyam Bihari Bansal, Deepak Pathania, Sidharth Kumar Sethi, Pranaw Kumar Jha, Ashish Nandwani, Manish Jain, Amit Mahapatra, Vijay Kher   +7 more
doaj   +1 more source

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database

Annals of Medicine, 2023
Introduction The aim of this study is to assess the outcomes of different induction therapies among mild to moderate immunological risk kidney transplants in the era tacrolimus and mycophenolate-derivate based maintenance.Methods This was a retrospective
Hatem Ali, Mahmoud Mohammed, Tibor Fülöp, Shafi Malik   +3 more
doaj   +1 more source